Skip to main content
  • GLP-1 Agonists Less Likely to Be Prescribed in Older Obese Patients With HFpEF: Single-Center Registry Analysis

    Patients with obesity and heart failure with preserved ejection fraction (HFpEF) who are older that 65 years are prescribed glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) less often, compared with younger patients, a new registry analysis shows.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details